Attached files

file filename
EX-32.1 - EX-32.1 - CRISPR Therapeutics AGcrsp-ex321_11.htm
EX-31.2 - EX-31.2 - CRISPR Therapeutics AGcrsp-ex312_7.htm
EX-31.1 - EX-31.1 - CRISPR Therapeutics AGcrsp-ex311_10.htm
EX-23.1 - EX-23.1 - CRISPR Therapeutics AGcrsp-ex231_6.htm
EX-10.32 - EX-10.32 - CRISPR Therapeutics AGcrsp-ex1032_254.htm
EX-10.31 - EX-10.31 - CRISPR Therapeutics AGcrsp-ex1031_516.htm
EX-10.30 - EX-10.30 - CRISPR Therapeutics AGcrsp-ex1030_515.htm
EX-10.29 - EX-10.29 - CRISPR Therapeutics AGcrsp-ex1029_517.htm
EX-10.28 - EX-10.28 - CRISPR Therapeutics AGcrsp-ex1028_255.htm
EX-10.25 - EX-10.25 - CRISPR Therapeutics AGcrsp-ex1025_256.htm
EX-4.1 - EX-4.1 - CRISPR Therapeutics AGcrsp-ex41_117.htm
EX-3.1 - EX-3.1 - CRISPR Therapeutics AGcrsp-ex31_84.htm
10-K - 10-K - CRISPR Therapeutics AGcrsp-10k_20191231.htm

Exhibit 21.1

Subsidiaries of the Registrant

 

Name of Subsidiary

 

Jurisdiction of Incorporation or Organization

CRISPR Therapeutics, Inc.

 

Delaware

CRISPR Therapeutics Ltd.

 

United Kingdom

TRACR Hematology Ltd

 

United Kingdom

CTX Financing GmbH

 

Switzerland

Casebia Therapeutics Limited Liability Partnership

 

United Kingdom

Casebia Therapeutics LLC

 

Delaware